Literature DB >> 35910061

Poorly differentiated carcinoma with neuroendocrine features in two patients with sinonasal tumours: a report of two cases.

Victor Chimezie Okebalama1, John Ifeanyi Nwadiokwu1,2, Ehioghae Osaze3, Ayeni Akinwunmi Ayodeji3, Obinna Mike Chinatu-Nwankwo4.   

Abstract

Neuroendocrine tumors can be described as rare, heterogeneous, epithelial tumours with principally neuroendocrine differentiation that can be harboured in the sinonasal cavities. Owing to the intermingling of its clinical, radiological and histopathological features, the diagnosis of poorly differentiated sinonasal carcinomas with neuroendocrine features is a daunting one. Many of these tumours have a poor prognosis. In our two cases, patients presented with nasal cavity obstruction and growth of 8 & 5-months duration, respectively. Intranasal growths with intracranial extensions were noted in computed tomography scans in both patients. Our first patient failed to complete his cycle of induction chemotherapy (Cisplatin and 5-fluorouracil) and died 8 months after presentation while our second patient completed his cycle of induction chemotherapy but died 1year, 6months, after presentation, as he was unable to get the planned radiotherapy. Indeed, late presentations, intracranial metastasis, and poor treatment compliance can contribute to the poor outcome of these tumours. Copyright: Victor Chimezie Okebalama et al.

Entities:  

Keywords:  Poorly differentiated; case report; neuroendocrine; sinonasal; tumour

Mesh:

Substances:

Year:  2022        PMID: 35910061      PMCID: PMC9288124          DOI: 10.11604/pamj.2022.42.37.34513

Source DB:  PubMed          Journal:  Pan Afr Med J


  20 in total

Review 1.  Esthesioneuroblastoma.

Authors:  Thomas J Ow; Diana Bell; Michael E Kupferman; Franco Demonte; Ehab Y Hanna
Journal:  Neurosurg Clin N Am       Date:  2013-01       Impact factor: 2.509

Review 2.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

3.  Sinonasal Carcinomas with Neuroendocrine Features: Histopathological Differentiation and Treatment Outcomes.

Authors:  Liuba Soldatova; Raewyn G Campbell; Ricardo L Carrau; Daniel M Prevedello; Paul Wakely; Bradley A Otto; Leo F Ditzel Filho
Journal:  J Neurol Surg B Skull Base       Date:  2016-04-26

Review 4.  Extrapulmonary small cell neuroendocrine carcinoma of the paranasal sinuses: a case report and review of the literature.

Authors:  Guang Han; Zhaohua Wang; Xiaofang Guo; Mingwei Wang; Huijing Wu; Dong Liu
Journal:  J Oral Maxillofac Surg       Date:  2012-02-11       Impact factor: 1.895

5.  Neuroblastomas and neuroendocrine carcinomas of the nasal cavity: a proposed new classification.

Authors:  E G Silva; J J Butler; B Mackay; H Goepfert
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

6.  Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.

Authors:  Elizabeth D Thompson; Edward B Stelow; Stacey E Mills; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

7.  Primary small cell carcinoma of the nasal cavity with an unusual oral manifestation.

Authors:  Marco Tarozzi; Federica Demarosi; Giovanni Lodi; Andrea Sardella; Antonio Carrassi
Journal:  J Oral Pathol Med       Date:  2007-04       Impact factor: 4.253

8.  Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors.

Authors:  Bin Xu; Runjan Chetty; Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2014-03-05

9.  Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome.

Authors:  Anna Likhacheva; David I Rosenthal; Ehab Hanna; Michael Kupferman; Franco Demonte; Adel K El-Naggar
Journal:  Head Neck Oncol       Date:  2011-07-27

Review 10.  Malignant Sinonasal Tumors: Update on Histological and Clinical Management.

Authors:  Alessandra Bracigliano; Fabiana Tatangelo; Francesco Perri; Giuseppe Di Lorenzo; Roberto Tafuto; Alessandro Ottaiano; Ottavia Clemente; Maria Luisa Barretta; Nunzia Simona Losito; Mariachiara Santorsola; Salvatore Tafuto
Journal:  Curr Oncol       Date:  2021-07-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.